in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Wacker Signs Licensing Deal with Xoma
11:55 AM MDT | June 23, 2008 | Deepti Ramesh
Wacker Biotech (Jena, Germany), a subsidiary of Wacker Chemie, says it has signed a licensing agreement with biopharmaceutical company Xoma (Berkeley, CA), to use Xoma’s bacterial cell expression technology for R&D. The agreement allows Wacker Biotech to combine its proprietary E. coli secretion technology with Xoma’s bacterial cell expression technology to produce antibodies and antibody fragments, Wacker Biotech says. Xoma will use Wacker Biotech’s E. coli secretion technology for a development project to produce an antibody fragment...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: